Viewing Study NCT05112666


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-25 @ 2:04 PM
Study NCT ID: NCT05112666
Status: COMPLETED
Last Update Posted: 2023-04-03
First Post: 2021-10-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-12-02
Start Date Type: ACTUAL
Primary Completion Date: 2022-08-26
Primary Completion Date Type: ACTUAL
Completion Date: 2022-08-26
Completion Date Type: ACTUAL
First Submit Date: 2021-10-28
First Submit QC Date: None
Study First Post Date: 2021-11-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-30
Last Update Post Date: 2023-04-03
Last Update Post Date Type: ACTUAL